ExoticRx · exoticrx.com/drugs/cangrelor
Kengreal
Direct-acting, reversible IV P2Y12 receptor antagonist that provides rapid, potent platelet inhibition with offset within 60 minutes of discontinuation.
Bleeding risk. Ultra-short acting — used when oral P2Y12 inhibitors cannot be given. Very limited veterinary data.
Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.
Cangrelor CRI dose rules from the ExoticRx formulary. Verify against current literature before clinical use; CRI rates differ from bolus dosing and route, dilution, and monitoring matter. Sign in for the complete per-species CRI protocol set.
| Species | Route | Rate | Indication | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | IV | 0.5–1 mcg/kg/minContinuous IV infusion | Acute antiplatelet therapy (peri-procedural) | Extrapolated | Veterinary Hematology Literature Review |
| Cat (Domestic) | IV | 0.5–1 mcg/kg/minContinuous IV infusion | Acute antiplatelet therapy | Extrapolated | Veterinary Hematology Literature Review |
Acute antiplatelet therapy (peri-procedural)
Acute antiplatelet therapy
Free-tier preview — dog and cat dosing. Pro and Student unlock all 2 species including reptiles, birds, pocket pets, livestock, and equine.
| Species | Route | Dose | Frequency | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | IV | 0.5–1 mcg/kg/min | Continuous IV infusion | Extrapolated | Veterinary Hematology Literature Review |
| Cat (Domestic) | IV | 0.5–1 mcg/kg/min | Continuous IV infusion | Extrapolated | Veterinary Hematology Literature Review |
Upgrade to Pro or Student to access full drug details including mechanism of action, warnings, dose ranges, and frequency.
View PlansSource citations and evidence levels available on the live page. Reference only — verify against current literature before clinical use.